[1. Aase K, VonEuler G, Li X et al. Vascular Endothelial Growth Factor-B-Deficient Mice Display an Atrial Conduction Defect // Circulation, 2001; 104: 358.-36410.1161/01.CIR.104.3.358]Search in Google Scholar
[2. Abbote A, Biondi-Zoccai GGL, Bussani R. et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure // J Am Coll Cardiol, 2003; 41(5): 753.-76010.1016/S0735-1097(02)02959-5]Search in Google Scholar
[3. Accornero F, VanBerlo JH, Benard MJ. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism // Circ Res, 2011; 109(3): 272.-28010.1161/CIRCRESAHA.111.240820]Search in Google Scholar
[4. Agapitov AV, Haynes WG. Role of endothelin in cardiovascular disease // J Renin Angiotensin Aldosterone Syst, 2002; 3 (1): 1-15]Search in Google Scholar
[5. Ahmed A, Johansson O, Folan-Curran J. Distribution of PGP 9.5, TH, NPY, SP and CGRP immunoreactive nerves in the rat and guinea pig atrioventricular valves and chordae // J Anat, 1997; 191: 547.-56010.1046/j.1469-7580.1997.19140547.x]Search in Google Scholar
[6. Baba HA, Takeda A, Takeda N et al. Left Ventricular Assist Device: Morphological, Molecular and Genetic Changes After Mechanical Support // Ostadal B., Nagano M., Dhalla N.S. Genes and Cardiovascular Function / London: Springer, 2011; 235-240]Search in Google Scholar
[7. Bellamo D, Headrick JP, Silins GU et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia //Circ Res, 2000; 86: 29.-3510.1161/01.RES.86.2.e29]Search in Google Scholar
[8. Bhavani SS, Parshuram JS, Nitish RM et al. Chromogranin A: a novel susceptibility gene for essential hypertension // Cell Mol Life Sci, 2010; 67: 861-874]Search in Google Scholar
[9. Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease // Cardiovasc Res, 2007; 76: 8-18]Search in Google Scholar
[10. Bold AJ, Borenstein HB, Veress AJ et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats // J Am Soc Nephrol, 2001; 13: 403.-40910.1681/ASN.V122403]Search in Google Scholar
[11. Brooks ES, Rodeheffer RJ, Reeder GS et al. Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation // J Am Coll Cardiol, 1990; 16(7): 1589.-159310.1016/0735-1097(90)90305-9]Search in Google Scholar
[12. Burninston JG, Saini A, Tan L et al. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo // J Mol Cell Cardiol, 2005; 39(2): 395.-39910.1016/j.yjmcc.2005.04.00115907929]Search in Google Scholar
[13. Bussani R, Abbate A, Biondi-Zoccai GGL et al. Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans // J Clin Pathol, 2003; 56: 672.-67610.1136/jcp.56.9.672177005812944550]Search in Google Scholar
[14. Canty JM. Coronary Blood Flow and Myocardial Ischemia // Bonow RO, Mann DL, Zipes DP. Braunwald`s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012; 1049.-1075]Search in Google Scholar
[15. Cea LB. Natriuretic peptide family: new aspects // Curr Med Chem Cardiovasc Hematol Agents, 2005; 3(2): 87.-9810.2174/156801605354430915853696]Search in Google Scholar
[16. Ceconi C, Ferrari R, Bachetti T. et al. Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality // Eur Heart J, 2002; 23: 967-974]Search in Google Scholar
[17. Chalajour F, Treede H, Gehling UM et al. Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve // Exp Cell Res, 2007; 313: 2326.-233510.1016/j.yexcr.2007.02.033]Search in Google Scholar
[18. Chen P, Chen L, Cao J et al. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death // Cardiovasc Res, 2001; 50: 409.-41610.1016/S0008-6363(00)00308-4]Search in Google Scholar
[19. Chenn H.H., Burnett J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system // J Cardiovasc Pharmaco, 1998; 32(3): 22.-28]Search in Google Scholar
[20. Chow LTC, Chow SSM, Anderson R.H et al. Autonomic Innervation of the Human Cardiac Conduction System: Changes from Infancy to Senility An Immunohistochemicaland Histochemical Analysis // Anat Rec, 2001; 264: 169-182]Search in Google Scholar
[21. Chow LT, Chow SS, Anderson RH et al. The innervation of the human myocardium at birth // J Anat, 1995; 187: 107.-114]Search in Google Scholar
[22. Chow LT, Chow SS, Anderson RH et al. The innervation of the human cardiac conduction system at birth // Brit Heart J, 1993; 69: 430.-43510.1136/hrt.69.5.43010251077686024]Search in Google Scholar
[23. Crick SJ, Wharton J, Sheppard MN et al. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study // Circulation, 1994; 89: 1697.-170810.1161/01.CIR.89.4.1697]Search in Google Scholar
[24. Crippa L, Bianci M, Colombo B et al. A new chromogranin A- dependent angiogenic switch activated by trombin // Blood, 2013; 121 (2): 392.-40210.1182/blood-2012-05-430314354411823190532]Search in Google Scholar
[25. Dashkevich A, Lemstrom KB, Nykanem AI. VEGF Receptor Signaling in the Cardiac Lymphatic System // Karunamuni G. The Cardiac Lymphatic System. -New York: Springer, 2013- 125.-14410.1007/978-1-4614-6774-8_9]Search in Google Scholar
[26. Davenport AP, Oreilly G, Molenaar P. Human Endothelin Receptors Characterized Using Reverse- Transcriptase-Polymerase Chain Reaction, in Situ Hybridisation and Subtype Selective Ligands BQ123 and BQ3020: Evidence for Expression of Etb Receptors in Human Vascular Smooth Muscle // J Cardiovasc Pharmacol, 1993; 22(8): 22.-2510.1097/00005344-199322008-000087509950]Search in Google Scholar
[27. Empel VPM., Bertrand ATA., Hofstra L et al. Myocyte apoptosis in heart failure // Cardiovasc Res, 2005; 67: 21 - 29]Search in Google Scholar
[28. Ferrera N. Molecular and viological properties of vascular endothelial growth factor // J Mol Med, 1999; 77: 527.-54310.1007/s00109990001910494799]Search in Google Scholar
[29. Ferrera N., Davis-Smyth T. The biology of vascular endothelial growth factor // Endocrine Reviews, 1997; 18(1): 4.-2510.1210/edrv.18.1.02879034784]Search in Google Scholar
[30. Fischer D, Rossa S, Landmesser U et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death // Eur Heart J, 2005; 26 (1): 65-69]Search in Google Scholar
[31. Forssmann WG, Richter R, Meyer M. The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilation system // Histochem Cell Biol, 1998; 110:335.-35710.1007/s0041800502959792413]Search in Google Scholar
[32. Fujitami Y, Ninomiya H, Okada T et al. Supression of Endothelin-1-induced Mitogenic Responses of Human Aortic Smooth Muscle Cells by Interleukin-1β // J Clin Invest, 1995; 95: 2474.-248210.1172/JCI1179482959287769093]Search in Google Scholar
[33. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation // J Cell Bio, 1992; 119(3): 493.-50110.1083/jcb.119.3.49322896651400587]Search in Google Scholar
[34. Genest J, Libby P. Lipoprotein Disorders in Cardiovascular Disease // Bonow RO, Mann DL, Zipes DP. Braunwald`s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012; 975.-995]Search in Google Scholar
[35. Gerber HP, Dixit V, Ferrera N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells // J Biol Chem, 1998; 273 (21): 13313.-1331610.1074/jbc.273.21.133139582377]Search in Google Scholar
[36. Glattard E, Angelone T, Strub JM, et al. Characterization of natural vasostatin-containing peptides in rat heart // The FEBS Journal, 2006; 273: 3311-3321]Search in Google Scholar
[37. Goetze JP, Alehagen U, Flyvbjerg A et al. Making sense of chromogranin A in heart disease // Lancet Diabetes Endocrinol, 2013; 1 (1): 7-8]Search in Google Scholar
[38. Goetze JP, Hilsted LM, Rehfeldand JF et al. Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure // Endocr Connect, 2014; 3: 47-56]Search in Google Scholar
[39. Gottieb RA, Burleson KO, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes // J Clin Invest, 1994; 94: 1621.-162810.1172/JCI1175042953227929838]Search in Google Scholar
[40. Hasan W. Autonomic cardiac innervation. Development and adult plasticity //Organogenesis, 2013; 9(3): 176.-19310.4161/org.24892389658923872607]Search in Google Scholar
[41. Heatwole LC. TUNEL Assay for Apoptotic Cells // Javois L.C. Methods in Molecular Biology: Immunocytochemical Methods and Protocols -2nd ed.- New Jersey: Humana Press, 1999; 141.-148]Search in Google Scholar
[42. Hengartner MO, Horvitz HR. Programmed cell death in Caenorhabditis elegans // Curr Opin Genetics Dev, 1994; 4: 581-586]Search in Google Scholar
[43. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy // J Investig Med, 2005; 53(7): 366.-370.10.2310/6650.2005.5370916297364]Search in Google Scholar
[44. Ishikawa Y, Akasaka Y, Ishii T et al. Sequential changes in localisation of repair-related proteins (heat shock protein 70, ubiquitin and vascular endothelial growth factor) in the different changes of myocardial infarction // Histopathology, 2000; 37: 546.-55410.1046/j.1365-2559.2000.00994.x11122437]Search in Google Scholar
[45. Kabara M, Tatsumi T, Kambayashi D et al. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model // J Cardiovasc Pharmacol, 2003; 41: 880.-88910.1097/00005344-200306000-0000812775965]Search in Google Scholar
[46. Kadzerski RM, Yanagisawa M. Endothelin system: The double edged sword in health and disease // Annu Rev Pharmacol Toxicol, 2001; 41: 851.-876 10.1146/annurev.pharmtox.41.1.85111264479]Search in Google Scholar
[47. Karu I, Starkopf J, Zilmer K et al. Growth Factors Serum Levels in Coronary Artery Disease Patients Scheduled for Bypass Surgery: Perioperative Dynamics and Comparisons with Healthy Volunteers // http://dx.doi.org/10.1155/2013/985404 (10.06.2014)10.1155/2013/985404374590823984427]Search in Google Scholar
[48. Kawai K, Quin F, Shite J et al. Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy // Am J Physiol Heart Circ Physiol, 2004; 287(3): 1003.-101210.1152/ajpheart.00797.200315105169]Search in Google Scholar
[49. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics // Br J Cancer, 1972; 26: 239.-25710.1038/bjc.1972.3320086504561027]Search in Google Scholar
[50. Krown KA, Page MT, Nguyen C et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death // J Clin Invest, 1996; 98(12): 2854.-286510.1172/JCI1191145077538981934]Search in Google Scholar
[51. Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides // Br J Pharmacol, 2012; 166 (2): 522-531]Search in Google Scholar
[52. Laslop A, Doblinger D, Weiss U. Proteolytic Processing of Chromogranins // Helle B., Aunis D. Chromogranins. Functional and Clinical Aspects. USA: Kluwer Academic Publishers, 2002; 155.-16510.1007/0-306-46837-9_1211192577]Search in Google Scholar
[53. Lee J, Gray A, Yuan J et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 // Cell Biol, 1996; 93: 1988.-199210.1073/pnas.93.5.1988398968700872]Search in Google Scholar
[54. Leri A, Claudio PP, Li Q. et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local reninangiotensin system and decreases the Bcl-2-to- Bax protein ratio in the cell // J Clin Invest, 1998; 101(7): 1326.-134210.1172/JCI3165087109525975]Search in Google Scholar
[55. Loh YP, Cheng Y, Mahata SK et al. Chromogranin A and Derived Peptides in Health and Disease // J Mol Neurosc, 2012; 48: 347.-35610.1007/s12031-012-9728-2340261522388654]Search in Google Scholar
[56. MacNulty EE, Plevin R, Wakelam MJO. Stimulation of the hydrolysis of phosphatidylinositol 4,5-bisphosphate and phosphatidylcholine by endothelin, a complete mitogen for Rat-1 fibroblasts // Biochem J, 1990; 272: 761.-76610.1042/bj272076111497742176477]Search in Google Scholar
[57. Maisel A, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis of heart failure // N Engl J Med, 2002; 347 (3): 161-167]Search in Google Scholar
[58. Mann D. Pathophysiology of Heart Failure // Bonow RO, Mann DL, Zipes DP. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012.- Pp. 487.-503]Search in Google Scholar
[59. Marron K, Wharton J, Sheppard MN et al. Distribution, Morphology, and Neurochemistry of Endocardial and Epicardial Nerve Terminal Arborizations in the Human Heart // Circulation, 1995; 92: 2343.-235110.1161/01.CIR.92.8.23437554220]Search in Google Scholar
[60. Molenaar P, Kuc RE, Davenport AP. Characterisation of two new ETB selective radioligands, [125I]- BQ3020 and [125I]-[Ala1,3,11,15] ET-1 in human heart // Brit J Pharmac, 1992; 107: 637.-63910.1111/j.1476-5381.1992.tb14498.x19077401472961]Search in Google Scholar
[61. Molenaar P, Oreilly G, Sharkey A. Characterisation and Localisation of Endotheli Receptor Subtypes in the Human Atrioventricular conducting System and Myocardium // Circ Res, 1993; 72(3): 526.-53810.1161/01.RES.72.3.526]Search in Google Scholar
[62. Mukoyama M, Nakao K, Hosada K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide // J Clin Inves, 1991; 87: 1402.-141210.1172/JCI115146]Search in Google Scholar
[63. Nakagawa O, Ogawa Y, Itoh H et al. Rapid Transcriptional Activation and Early mRNA Turnover of Brain Natriuretic Peptide in Cardiocyte Hypertrophy // J Clin Inves, 1995; 96: 1280-1287]Search in Google Scholar
[64. Narula J, Haider N, Virmani R et al. Apoptosis in myocytes in end-stage heart failure // N Engl J Med, 1996; 335(16): 1182.-118910.1056/NEJM199610173351603]Search in Google Scholar
[65. Nichols M, Townsend N, Scarborough P et al. Cardiovascular disease in Europe 2014: epidemiological update // Eur Heart J, 2014; 35: 2950.-295910.1093/eurheartj/ehu299]Search in Google Scholar
[66. Nobels FRE, Kwekkeboom DJ, Bouillon R et al. Review. Chromogranin A: it`s clinical value as marker of neuroendocrine tumors // Eur J Clin Inves, 1998; 28: 431.-44010.1046/j.1365-2362.1998.00305.x]Search in Google Scholar
[67. Noireaund J, Andiantsitohaina R. Recent Insights in the Paracrine Modulation of Cardiomyocyte Contractility by Cardiac Endothelial Cells // BioMed Research International, BioMed Research International, vol. 2014, Article ID 923805, 10 pages, 2014. doi:10.1155/2014/92380510.1155/2014/923805]Search in Google Scholar
[68. Ogawa Y, Nakao K, Nakagawa O et al. Human C-type natriuretic peptide. Characterization of the gene and peptide //Hypertension, 1992; 19(6): 809.-81310.1161/01.HYP.19.6.809]Search in Google Scholar
[69. Olivetti G, Quaini F, Lagrasta C et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart // J Mol Cell Cardiol, 1996; 28(9): 2005.-201610.1006/jmcc.1996.0193]Search in Google Scholar
[70. Olofsson B, Pajusala K, Kaipainen A et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells //Cell Biology, 1996; 93: 2576.-258110.1073/pnas.93.6.2576]Search in Google Scholar
[71. Park EJ, Chen HH, Winer J et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR // J Biol Chem, 1994; 269(41): 25646.-2565410.1016/S0021-9258(18)47298-5]Search in Google Scholar
[72. Pearlman JD, Hibberd MG, Chuang ML et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis // Nature Medicine, 1995; 1(10): 1085-1089 ]Search in Google Scholar
[73. Pieroni M, Corti A, Tota B et al. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function // Eur Heart J, 2007; 28: 1117- 1127]Search in Google Scholar
[74. Pilmane M, Ozoliņa L, Ābola Z et al. Growth Factors, Their Receptors, Neuropeptide-Containing Innervation, and Matrix Metalloproteinases in the Proximal and Distal Ends of the Esophagus in Children With esophageal Atresia // Medicina, 2011; 47(8): 453-460]Search in Google Scholar
[75. Plumpton C, Champeney R, Ashby MJ et al. Characteriszation of Endothelin Isoforms in Human Heart: Endothelin-2 Demonstrated // J Cardiovasc Pharmac, 1993; 22(8): 26.-2810.1097/00005344-199322008-00009]Search in Google Scholar
[76. Pucci A, Wharton J, Arbustini E et al. Localization of brain and atrial natriuretic peptide in human and porcine heart // Int J Cardiol, 1992; 34: 237.-24710.1016/0167-5273(92)90020-4]Search in Google Scholar
[77. Rabkin SW. Review Article. Apoptosis in Human Acute Myocardial Infarction: The Rationale for Clinical Trials of Apoptosis Inhibition in Acute Myocardial Infarction // Scholarly Research Exchange, Volume 2009, Article ID 979318, http://dx.doi.org/10.3814/2009/979318 (10.06.2015)10.3814/2009/979318]Search in Google Scholar
[78. Rabkin SW, Kong JY. Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide // Am J Physiol Heart Circ Physiol, 2000; 279(6): 3089.-310010.1152/ajpheart.2000.279.6.H3089]Search in Google Scholar
[79. Rajamannan NM, Nealis T., Subramainiam M. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation // Circulation, 2005; 111(24): 3296.-330110.1161/CIRCULATIONAHA.104.473165]Search in Google Scholar
[80. Rajamannan NM, Subramainiam M, Rickard D et al. Human aortic valve calcification is associated with an osteoblast phenotype //Circulation, 2003; 107(17): 2181.-218410.1161/01.CIR.0000070591.21548.69]Search in Google Scholar
[81. Rechardt L, Aalto-Setala K, Purjeranta M et al. Peptidergic innervation of human arial myocardium: an electron microscopical and immunocytochemical study // J Auton Nerv Syst, 1986; 17: 21.-3210.1016/0165-1838(86)90041-X]Search in Google Scholar
[82. Rosjo H, Masson S, Latini R et al. Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial // Eur J Heart Fail, 2010; 12: 549-556]Search in Google Scholar
[83. Saraste A, Pulkki K, Kallajoni M et al. Apoptosis in Human Acute Myocardial Infarction // Circulation, 1997; 95: 320.-32310.1161/01.CIR.95.2.3209008443]Search in Google Scholar
[84. Schaper J, Lorenz-Meyer S, Suzuki K The Role of Apoptosis in Dilated Cardiomyopathy // Herz, 1999; 24(3): 219.-22410.1007/BF0304496410412645]Search in Google Scholar
[85. Schirger JA, Heublein DM, Chen HH et al. Presence of Dendroaspis natriuretic peptidelike immunoreactivity in human plasma and its increase during human heart failure // Mayo Clinic Proceedings, 1999; 74(2): 126.-13010.4065/74.2.12610069348]Search in Google Scholar
[86. Shibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis // Genes and Cancer, 2011; 12(2): 1097.-110510.1177/1947601911423031]Search in Google Scholar
[87. Shubeita HE, McDonough PM, Harris AN et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy // J Biol Chem, 1990; 265 (33): 20555.-2056210.1016/S0021-9258(17)30538-0]Search in Google Scholar
[88. Sinagra G, Bussani R, Abbate A et al. Left Ventricular Diastolic Filling Pattern at Doppler Echocardiography and Apoptotic Rate in Fatal Acute Myocardial Infarction // Am J Cardiol, 2007; 99(3):307.-30910.1016/j.amjcard.2006.08.025]Search in Google Scholar
[89. Soni Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis // Human Pathology, 2003; 34(8): 756.-76310.1016/S0046-8177(03)00245-4]Search in Google Scholar
[90. Statistical data on population mortality // http://www.spkc.gov.lv/veselibas-aprupes-statistika/ (14.06.2015)]Search in Google Scholar
[91. Stewart DJ, Kubac G, Costello KB. Increased plasma endothelin-1 in the early hours of acute myocardial infarction // J Am Coll Cardiol, 1991; 18(1): 38.-4310.1016/S0735-1097(10)80214-1]Search in Google Scholar
[92. Suzuki Y, Suzuki H, Ohtake R et al. Changes in the plasma and urine alpha human atrial natriuretic peptide (alpha hANP) concentration in patients with thyroid disorders // Endocrinologia Japonica, 1988; 35(6): 907.-91310.1507/endocrj1954.35.907]Search in Google Scholar
[93. Syvaranta S, Helske S, Laine M. et al. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis // Arterioscler Thromb Vasc Biol, 2010; 30(6): 1220.-122710.1161/ATVBAHA.109.198267]Search in Google Scholar
[94. Takemura G, Fujiwara H, Mukoyama M. et al. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy // Circulation, 1991; 83(1): 181.-19010.1161/01.CIR.83.1.181]Search in Google Scholar
[95. Takemura G, Takatsu Y, Doyama K. et al. Expression of Atrial and Brain Natriuretic Peptides and their Genes in Hearts of Patients with Cardiac Amyloidosis // J Am Coll Cardiol, 1998; 31: 254.-26510.1016/S0735-1097(98)00045-X]Search in Google Scholar
[96. Teerlink JR. Recent Heart Failure Trials of Neurohormonal Modulation (OVERTURE and ENABLE): Approaching the Asymtote of Efficacy? // J Card Fail, 2002; 8(3): 124]Search in Google Scholar
[97. Thompson RJ, Doran JF, Jackson P. Et al. PGP 9.5- a new marker for vertebrate neurons and neuroendocrine cells // Brain Research, 1983; 278: 224.-22810.1016/0006-8993(83)90241-X]Search in Google Scholar
[98. Tomanek RJ, Zheng W, Yue X. Growth factor activation in myocardial vascularization: Therapeutic implications // Mol Cell Biol, 2004; 264: 3.-1110.1023/B:MCBI.0000044369.88528.a3]Search in Google Scholar
[99. Tota B, Cerra CM, Gattuso. Review. Catheholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of whip- brake system of the endocrine heart // J Exp Biol, 2010; 213: 3081.-3103 10.1242/jeb.027391]Search in Google Scholar
[100. Uusimaa P, Ruskoaho H, Vuolteenaho O. et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction // Int J Cardiol, 1999; 69: 5.-1410.1016/S0167-5273(99)00007-8]Search in Google Scholar
[101. Veinot JP, Gattinger DA, Fliss H. Early apoptosis in human myocardial infarcts // Hum Path, 1997; 28(4): 485.-49210.1016/S0046-8177(97)90039-3]Search in Google Scholar
[102. Vincenti V, Cassano C, Rocchi M et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 // Circulation, 1996; 93: 1493.-149510.1161/01.CIR.93.8.1493]Search in Google Scholar
[103. Vracko R, Thorning D, Frederickson RG. Nerve Fibers in Human Myocardial Scars // Hum Path, 1998; 22: 138.-146.10.1016/0046-8177(91)90035-N]Search in Google Scholar
[104. Weiergraber M, Pereverzev A, Vajna R, Henry M. et al. Immunodetection of alpha1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney // J Histochem Cytochem, 2000; 48 (6): 807.-81910.1177/00221554000480060910820154]Search in Google Scholar
[105. Wharton J, Polak J, Gordon L. et al. Immunohistochemical Demonstration of Human Cardiac Innervation Before and After Transplantation // Circ Res, 1990; 66(4): 900.-912.10.1161/01.RES.66.4.9002317894]Search in Google Scholar
[106. Yanagisawa M, Kurihora H, Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells //Nature, 1988; 332:411.-41510.1038/332411a02451132]Search in Google Scholar
[107. Zeiher AM, Goebel H, Schachinger V et al. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina // Circulation, 1995; 91: 941.-94710.1161/01.CIR.91.4.941]Search in Google Scholar
[108. Zheng W, Seftor E, Meininger CJ. et al. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta // Am J Physiol Heart Circ Physiol, 2001; 280: 909.-91710.1152/ajpheart.2001.280.2.H90911158993]Search in Google Scholar
[109. Zolk O, Böhm M. The role of the cardiac endothelin system in heart failure // Nephrol Dial Transplant, 2000; 15 (6): 758-760]Search in Google Scholar